Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 2nd International Conference on Neurological Disorders and Stroke The Oberoi Dubai, Dubai, UAE.

Day 1 :

OMICS International Stroke 2016 International Conference Keynote Speaker Saleh Baeesa photo
Biography:

TBA

Abstract:

Objective : Malignant middle cerebral artery infarction is known to be associated with significant rates of mortality and morbidity. This study was undertaken to assess the immediate and one-year outcome of this intervention and to present our experience from two tertiary centers in western Saudi Arabia.\r\nMethods: The authors conducted a retrospective study to evaluate patients who underwent decompressive hemicraniectomy between November 2010- December 2015 due to clinical deterioration from space-occupying middle cerebral artery infarct. The patients were followed for at least one year after intervention using Barthel Index (BI) & modified Rankin Scale (mRS) as measures for functional independence.\r\nResults: Sex patients were included in the study. The mean age was 41.57 years and, the mean preoperative Glasgow Coma Scale (GCS) score and NIH Stroke Scale were 6.8 and 15, respectively. The mean time from stroke onset to surgery was 48.8 hours. The mean immediate postoperative GCS was 5.7. Thirty-day survival rate was 66% with mortality reaching up to 50% at one year. Among survivors, the mean mRS score of 4.6 (SD 1.53), 66% were entirely dependent (BI 0-20), 33% were partially dependent (BI 60–95) at one-year post surgery, and only one patient remained in a vegetative state.\r\nConclusion : Survival after decompressive hemicraniectomy is better than previously reported ; this might be explained by early intervention & patients\' young age in this series. Functional outcome was found to be highly variable, thus further studies with larger number of patients are encouraged to examine functional outcome predictors among survivors. \r\n

Keynote Forum

M Fayez Al Homsi

University of Sharjah, United Arab Emirates

Keynote: Dehydration exacerbates cerebral microvascular responses to hyperthermia

Time : 11:00-11:40

OMICS International Stroke 2016 International Conference Keynote Speaker M Fayez Al Homsi  photo
Biography:

Homsi completed his MD at the University of Damascus School of Medicine, did his postdoctoral studies at the University of Illinois School of Medicine in the US; then became American Board of Pathology Diplomat and Fellow of the College of American Pathologists in 1990. Currently, he is the Chairman of Neurosciences Unit, College of Medicine, University of Sharjah, and Senior Consultant Pathologist at the University Hospital Sharjah, UAE. He has presented more than 90 conference papers, published five books and book chapters, and more than 40 papers in reputed journals. rnrn

Abstract:

Heatstroke is a major health problem in Arabian Gulf region, especially during the annual Pilgrimage to Mekkah. Collaborating closely with the Microcirculation group of the UAE University in Al Ain initially, and later with the Heat Injury Group at King Faisal Specialist Hospital and Research Center, this work is concerned with experimental procedure involving the in vivo animal model. Spraque-Dawley rats and C57 BL/6 mice, for induced thrombosis of cerebral microcirculation, utilizing hyperthermia, photochemical means, and dehydration to test susceptibility to thrombosis in cerebral microvasculature. Dehydration enhances platelet aggregation in pial arterioles which may lead to stroke. The histological and ultrastructural examination of the cerebral vessels, capillaries and surrounding milieu of dehydrated animals may reveal the cellular basis for this phenomenon. Possible means to alleviate or even reverse the effects of hyperthermia, photochemical and dehydration effects are also explored. This work has already led to several publications.rnrnCurrently, advancing the above work is taking place at the University of Sharjah Research Institute and several publications on the subject are expected to add more knowledge to the current literature.rn

Keynote Forum

Shireen Qureshi

Johns Hopkins Aramco Healthcare, Saudi Arabia

Keynote: Cardio Embolic Stroke

Time : 11:40-12:10

OMICS International Stroke 2016 International Conference Keynote Speaker Shireen Qureshi photo
Biography:

Shireen Qureshi, is a Consultant Neurologist/ Clinical Neurophysiologist and Head Neurologist, Subspecialty Medicine, at Johns Hopkins Aramco Healthcare Company. Shireen Qureshi is a Fellow in the Royal College of Physicians and Surgeons of Canada in the specialty of Neurology, a Member of the American Academy of Neurology, and a Member of the Canadian Society of Clinical Neurophysiologists. Graduate of King Faisal University/ Dammam University Neurology Residency at university of Toronto 2003 Qureshi is active in many organizations. She is currently the Head of the Scientific Committee and Vice President of the Saudi Stroke Association, a Member of the executive board of the Saudi Neurology Society

Abstract:

Stroke continues to have a major impact on the public health of our nation. Preventing stroke is a key to reducing its societal burden from a human and financial perspective. WHO deemed stroke as second leading cause of morbidity and mortality. Stroke (ischemic and hemorrhagic) constitutes 7% of all deaths annually in North America and Western Europe. In Saudi Arabia, accurate estimate is lacking, however, based on an older provincial population-based survey, the estimate is 30/100,000 and about one every 6 minutes. Stroke prevention is being transformed from a personal style or belief into evidence-based medicine. Ischemic stroke constitute about 70-80% of all strokes and is not a single disease; it is a system of diverse etiologies and pathogenic mechanisms. Although epidemiological realities are distressing, major advances in secondary stroke prevention and to a lesser extent, in primary prevention, has been elucidated. Despite the fact that the largely artificial distinction of primary and secondary prevention has become elusive, with the multitude of risk factors added together in different individual poses similar risk, hence, equally aggressive non-pharmacological and pharmacological intervention. Considerable research has led to a better delineation of risk factors, as well as an expanded understanding of pathophysiological subtypes. Atherosclerosis of the brain and heart vessels plays a predominant pathological role. Large artery atherosclerosis leads to hypo perfusion or atherogenic emboli, whereas micro atheroma and lipohyalinosis of small penetrating vessels cause lacunar infarcts. Approximately 20% of ischemic strokes are due to cardio embolism, commonly due to atrial fibrillation of up to 45%. 30% are cryptogenic and less than 5% due to a variety of unusual causes. Stroke research has evolved over the past decade elaborating that; different subtypes of stroke respond differently to specific interventions for stroke prevention of which cardio embolic strokes bear a big toll.